Acumen Pharmaceuticals Stock Analysis

Acumen Stock Analysis Notes

About 65.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acumen Pharmaceuticals recorded a loss per share of 2.21. The entity had not issued any dividends in recent years. Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimers disease. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. Acumen Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. For more info on Acumen Pharmaceuticals please contact Daniel MBA at 617 344 4190 or go to https://acumenpharm.com.

Acumen Pharmaceuticals Investment Alerts

Acumen Largest EPS Surprises

View All Earnings Estimates

Acumen Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Acumen Stock Institutional Investors

Note, although Acumen Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Acumen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 152.04 M.

Acumen Profitablity

Management Efficiency

Acumen Pharmaceuticals has return on total asset (ROA) of (0.4223) % which means that it has lost $0.4223 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8593) %, meaning that it created substantial loss on money invested by shareholders. Acumen Pharmaceuticals' management efficiency ratios could be used to measure how well Acumen Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.4 in 2026. Return On Capital Employed is likely to drop to -0.51 in 2026. At this time, Acumen Pharmaceuticals' Net Tangible Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 73.3 M in 2026, whereas Other Assets are likely to drop 0.86 in 2026.

Technical Drivers

As of the 15th of February 2026, Acumen Pharmaceuticals shows the Downside Deviation of 4.66, risk adjusted performance of 0.0879, and Mean Deviation of 4.32. Acumen Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Acumen Pharmaceuticals variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Acumen Pharmaceuticals is priced correctly, providing market reflects its regular price of 2.51 per share. Please also double-check Acumen Pharmaceuticals total risk alpha, which is currently at 0.1374 to validate the company can sustain itself at a future point.

Acumen Pharmaceuticals Price Movement Analysis

Acumen Pharmaceuticals Insider Trading Activities

Acumen Pharmaceuticals Outstanding Bonds

Acumen Pharmaceuticals Predictive Daily Indicators

Acumen Pharmaceuticals Forecast Models

Acumen Pharmaceuticals' time-series forecasting models are one of many Acumen Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Acumen Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Acumen Pharmaceuticals Bond Ratings

Acumen Pharmaceuticals financial ratings play a critical role in determining how much Acumen Pharmaceuticals have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Acumen Pharmaceuticals' borrowing costs.

Acumen Pharmaceuticals Debt to Cash Allocation

Acumen Pharmaceuticals currently holds 29.7 M in liabilities. Acumen Pharmaceuticals has a current ratio of 36.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Acumen Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Acumen Pharmaceuticals Total Assets Over Time

Acumen Pharmaceuticals Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Acumen Pharmaceuticals uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Acumen Pharmaceuticals Debt Ratio

5.78

It appears most of the Acumen Pharmaceuticals' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Acumen Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Acumen Pharmaceuticals, which in turn will lower the firm's financial flexibility.

Acumen Pharmaceuticals Corporate Bonds Issued

Acumen Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Acumen Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acumen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Acumen Pharmaceuticals. By using and applying Acumen Stock analysis, traders can create a robust methodology for identifying Acumen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acumen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Acumen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Acumen Pharmaceuticals stock analysis indicators help investors evaluate how Acumen Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Acumen Pharmaceuticals shares will generate the highest return on investment. By understating and applying Acumen Pharmaceuticals stock analysis, traders can identify Acumen Pharmaceuticals position entry and exit signals to maximize returns.

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.